Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ResMed.
RELATED STOCKHEAD STORIES
News
ASX Small Caps Lunch Wrap: Who got the worst kind of welcome home last week?
Experts
SUNDAY ROAST: The stocks that lit a fire under our experts this week
Health & Biotech
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff
News
Traders’ Diary: A week of War, Worry and Wall Street earnings
News
ASX Large Caps: Shares snap five-day winning streak, CSL up on dip buying, Fletcher denies selling faulty products
News
ASX Large Caps: ASX falls on first trading day of October as US avoids government shutdown
News
ASX Large Caps: Inflation climbs, shares down as gold and insurance stocks lead decliners
News
Selfwealth names top ASX gainers for August; UBS says sell them in September
News
Has the Danish pharma Novo Nordisk won the war on obesity?
News
Closing Bell: Minus Energy, the ASX benchmark and small cap indices had a silly day of depressing trade
Health & Biotech
ASX Biotech August Winners: Sector down despite CSL and Cochlear’s strong results, but don’t panic…
Health & Biotech
ScoPo’s Powerplays: CSL leads ASX health stocks down is reporting season; ‘we weren’t expecting that’
Health & Biotech
ScoPo’s Powerplays: ASX health stock fall but hold onto your hat for reporting season
News
ASX Large Caps: Shares down -1pc this week, Resmed weighs but Dicker Data surges on bumper first half
Health & Biotech
ASX Health Stocks: Mesoblast crashes 54pc after FDA says it needs more data for approval
News
Top 10 at 10: Koonenberry Gold aims for big win at the Bellagio… prospect
Health & Biotech